Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Efficacy and safety of prolonged-release tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus - a Phase 2, open-label, single-arm, one-way crossover study.

Rubik J, Debray D, Kelly D, Iserin F, Webb NJA, Czubkowski P, Vondrak K, Sellier-Leclerc AL, Rivet C, Riva S, Tönshoff B, D'Antiga L, Marks SD, Reding R, Kazeem G, Undre N.

Transpl Int. 2019 Jul 20. doi: 10.1111/tri.13479. [Epub ahead of print]

PMID:
31325368
2.

Escherichia coli-associated hemolytic uremic syndrome and severe chronic hepatocellular cholestasis: complication or side effect of eculizumab?

Mauras M, Bacchetta J, Duncan A, Lavocat MP, Rohmer B, Javouhey E, Collardeau-Frachon S, Sellier-Leclerc AL.

Pediatr Nephrol. 2019 Jul;34(7):1289-1293. doi: 10.1007/s00467-019-04234-6. Epub 2019 Apr 8.

PMID:
30963282
3.

Comparative pharmacokinetics of tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus to prolonged-release tacrolimus formulation.

Rubik J, Debray D, Iserin F, Vondrak K, Sellier-Leclerc AL, Kelly D, Czubkowski P, Webb NJA, Riva S, D'Antiga L, Marks SD, Rivet C, Tönshoff B, Kazeem G, Undre N.

Pediatr Transplant. 2019 Jun;23(4):e13391. doi: 10.1111/petr.13391. Epub 2019 Apr 1.

PMID:
30932313
4.

Complement Gene Variants and Shiga Toxin-Producing Escherichia coli-Associated Hemolytic Uremic Syndrome: Retrospective Genetic and Clinical Study.

Frémeaux-Bacchi V, Sellier-Leclerc AL, Vieira-Martins P, Limou S, Kwon T, Lahoche A, Novo R, Llanas B, Nobili F, Roussey G, Cailliez M, Ulinski T, Deschênes G, Alberti C, Weill FX, Mariani P, Loirat C.

Clin J Am Soc Nephrol. 2019 Mar 7;14(3):364-377. doi: 10.2215/CJN.05830518. Epub 2019 Jan 23.

PMID:
30674459
5.

Eculizumab and thrombotic microangiopathy after hematopoietic stem cell transplantation: A report on its efficacy and safety in two pediatric patients.

Genere L, Bacchetta J, Bertrand Y, Javouhey E, Cheikh N, Sellier-Leclerc AL.

Arch Pediatr. 2018 Nov;25(8):485-488. doi: 10.1016/j.arcped.2018.09.011. Epub 2018 Oct 16.

PMID:
30340942
6.

Skin microvascular dysfunction as an early cardiovascular marker in primary hyperoxaluria type I.

Bruel A, Bacchetta J, Ginhoux T, Rodier-Bonifas C, Sellier-Leclerc AL, Fromy B, Cochat P, Sigaudo-Roussel D, Dubourg L.

Pediatr Nephrol. 2019 Feb;34(2):319-327. doi: 10.1007/s00467-018-4081-5. Epub 2018 Oct 1.

PMID:
30276532
7.

Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study.

Percheron L, Gramada R, Tellier S, Salomon R, Harambat J, Llanas B, Fila M, Allain-Launay E, Lapeyraque AL, Leroy V, Adra AL, Bérard E, Bourdat-Michel G, Chehade H, Eckart P, Merieau E, Piètrement C, Sellier-Leclerc AL, Frémeaux-Bacchi V, Dimeglio C, Garnier A.

Pediatr Nephrol. 2018 Aug;33(8):1385-1394. doi: 10.1007/s00467-018-3903-9. Epub 2018 Mar 23.

PMID:
29572749
8.

Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy.

Le Quintrec M, Lapeyraque AL, Lionet A, Sellier-Leclerc AL, Delmas Y, Baudouin V, Daugas E, Decramer S, Tricot L, Cailliez M, Dubot P, Servais A, Mourey-Epron C, Pourcine F, Loirat C, Frémeaux-Bacchi V, Fakhouri F.

Am J Kidney Dis. 2018 Jul;72(1):84-92. doi: 10.1053/j.ajkd.2017.11.019. Epub 2018 Feb 9.

PMID:
29429752
9.

[Pediatric nephrology: What should an adult nephrologist know about these diseases?]

Lemoine S, Cochat P, Bertholet-Thomas A, Levi C, Bonnefoy C, Sellier-Leclerc AL, Bacchetta J.

Nephrol Ther. 2017 Dec;13(7):495-504. doi: 10.1016/j.nephro.2017.01.025. Epub 2017 Oct 12. Review. French.

PMID:
29031489
10.

Infection-related hospitalizations after kidney transplantation in children: incidence, risk factors, and cost.

Hogan J, Pietrement C, Sellier-Leclerc AL, Louillet F, Salomon R, Macher MA, Berard E, Couchoud C.

Pediatr Nephrol. 2017 Dec;32(12):2331-2341. doi: 10.1007/s00467-017-3737-x. Epub 2017 Jul 25.

PMID:
28744628
11.

C3 glomerulopathy and eculizumab: a report on four paediatric cases.

Lebreton C, Bacchetta J, Dijoud F, Bessenay L, Fremeaux-Bacchi V, Sellier-Leclerc AL.

Pediatr Nephrol. 2017 Jun;32(6):1023-1028. doi: 10.1007/s00467-017-3619-2. Epub 2017 Feb 24.

PMID:
28236143
12.

Epidemiology of idiopathic nephrotic syndrome in children: endemic or epidemic?

Dossier C, Lapidus N, Bayer F, Sellier-Leclerc AL, Boyer O, de Pontual L, May A, Nathanson S, Orzechowski C, Simon T, Carrat F, Deschênes G.

Pediatr Nephrol. 2016 Dec;31(12):2299-2308. Epub 2016 Oct 24.

PMID:
27778092
13.

Calcium balance in pediatric online hemodiafiltration: Beware of sodium and bicarbonate in the dialysate.

Bacchetta J, Sellier-Leclerc AL, Bertholet-Thomas A, Carlier MC, Cartier R, Cochat P, Ranchin B.

Nephrol Ther. 2015 Nov;11(6):483-6. doi: 10.1016/j.nephro.2015.03.006. Epub 2015 Jul 10.

PMID:
26165800
14.

Mutation Update of the CLCN5 Gene Responsible for Dent Disease 1.

Mansour-Hendili L, Blanchard A, Le Pottier N, Roncelin I, Lourdel S, Treard C, González W, Vergara-Jaque A, Morin G, Colin E, Holder-Espinasse M, Bacchetta J, Baudouin V, Benoit S, Bérard E, Bourdat-Michel G, Bouchireb K, Burtey S, Cailliez M, Cardon G, Cartery C, Champion G, Chauveau D, Cochat P, Dahan K, De la Faille R, Debray FG, Dehoux L, Deschenes G, Desport E, Devuyst O, Dieguez S, Emma F, Fischbach M, Fouque D, Fourcade J, François H, Gilbert-Dussardier B, Hannedouche T, Houillier P, Izzedine H, Janner M, Karras A, Knebelmann B, Lavocat MP, Lemoine S, Leroy V, Loirat C, Macher MA, Martin-Coignard D, Morin D, Niaudet P, Nivet H, Nobili F, Novo R, Faivre L, Rigothier C, Roussey-Kesler G, Salomon R, Schleich A, Sellier-Leclerc AL, Soulami K, Tiple A, Ulinski T, Vanhille P, Van Regemorter N, Jeunemaître X, Vargas-Poussou R.

Hum Mutat. 2015 Aug;36(8):743-52. doi: 10.1002/humu.22804. Epub 2015 Jun 11. Review.

PMID:
25907713
15.

Eculizumab in neonatal hemolytic uremic syndrome with homozygous factor H deficiency.

Michaux K, Bacchetta J, Javouhey E, Cochat P, Frémaux-Bacchi V, Sellier-Leclerc AL.

Pediatr Nephrol. 2014 Dec;29(12):2415-9. doi: 10.1007/s00467-014-2933-1. Epub 2014 Aug 23.

PMID:
25149852
16.

Prevalence of herpesviruses at onset of idiopathic nephrotic syndrome.

Dossier C, Sellier-Leclerc AL, Rousseau A, Michel Y, Gautheret-Dejean A, Englender M, Madhi F, Charbit M, Ulinski T, Simon T, Jacqz-Aigrain E, Deschênes G.

Pediatr Nephrol. 2014 Dec;29(12):2325-31. doi: 10.1007/s00467-014-2860-1. Epub 2014 Jun 5.

PMID:
24899237
17.

Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome.

Sellier-Leclerc AL, Belli E, Guérin V, Dorfmüller P, Deschênes G.

Pediatr Nephrol. 2013 Sep;28(9):1875-9. doi: 10.1007/s00467-013-2485-9. Epub 2013 May 23.

PMID:
23700173
18.

Childhood onset diabetes posttransplant in a girl with TCF2 mutation.

Tudorache E, Sellier-Leclerc AL, Lenoir M, Tubiana-Rufi N, Bensman A, Bellanne-Chantelot C, Ulinski T.

Pediatr Diabetes. 2012 Sep;13(6):e35-9. doi: 10.1111/j.1399-5448.2011.00842.x. Epub 2012 Jan 20. Erratum in: Pediatr Diabetes. 2013 Feb;14(1):80. Toubiana, Nadia [corrected to Tubiana-Rufi, Nadia].

PMID:
22260488
19.

Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery.

Sellier-Leclerc AL, Baudouin V, Kwon T, Macher MA, Guérin V, Lapillonne H, Deschênes G, Ulinski T.

Nephrol Dial Transplant. 2012 Mar;27(3):1083-9. doi: 10.1093/ndt/gfr405. Epub 2011 Aug 1.

PMID:
21810762
20.

Acute tubulointerstitial nephritis.

Ulinski T, Sellier-Leclerc AL, Tudorache E, Bensman A, Aoun B.

Pediatr Nephrol. 2012 Jul;27(7):1051-7. doi: 10.1007/s00467-011-1915-9. Epub 2011 Jun 3. Review.

PMID:
21638156
21.

Congenital nephrotic syndrome with acute renal failure: questions.

Tudorache E, Hogan J, Dourthe ME, Quinet B, Grimprel E, Sellier-Leclerc AL, Ulinski T.

Pediatr Nephrol. 2012 Jan;27(1):47, 49-50. doi: 10.1007/s00467-011-1842-9. Epub 2011 May 24. No abstract available.

PMID:
21607629
22.

Plasmatherapy in atypical hemolytic uremic syndrome.

Loirat C, Garnier A, Sellier-Leclerc AL, Kwon T.

Semin Thromb Hemost. 2010 Sep;36(6):673-81. doi: 10.1055/s-0030-1262890. Epub 2010 Sep 23. Review.

PMID:
20865645
23.

Rituximab efficiency in children with steroid-dependent nephrotic syndrome.

Sellier-Leclerc AL, Macher MA, Loirat C, Guérin V, Watier H, Peuchmaur M, Baudouin V, Deschênes G.

Pediatr Nephrol. 2010 Jun;25(6):1109-15. doi: 10.1007/s00467-010-1465-6. Epub 2010 Mar 18.

PMID:
20238230
24.

A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells.

Sellier-Leclerc AL, Duval A, Riveron S, Macher MA, Deschenes G, Loirat C, Verpont MC, Peuchmaur M, Ronco P, Monteiro RC, Haddad E.

J Am Soc Nephrol. 2007 Oct;18(10):2732-9. Epub 2007 Sep 12.

25.

Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.

Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, Boudailliez B, Bouissou F, Deschenes G, Gie S, Tsimaratos M, Fischbach M, Morin D, Nivet H, Alberti C, Loirat C; French Society of Pediatric Nephrology.

J Am Soc Nephrol. 2007 Aug;18(8):2392-400. Epub 2007 Jun 28.

26.

[Hereditary hemolytic uremic syndromes and thrombotic thrombocytopenic purpura].

Loirat C, Sellier-Leclerc AL, Frémeaux-Bacchi V, Dragon-Durey A, Girma JP, Veyradier A.

Nephrol Ther. 2006 Jan;2 Suppl 2:S149-61. Review. French.

PMID:
17373216

Supplemental Content

Loading ...
Support Center